Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular polypill plus nurse education in acute coronary syndrome
2025-524751-32-00Phase 4Authorised
- Sponsor
- Fundación Epic
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of aspirin + atorvastatin + ramipril in acute coronary syndrome (ACS) and myocardial infarction (MI) (2 arms), sponsored by Fundación Epic. Primary endpoint: Combined adherence at 1 year. Planned start Mar 2026; status: authorised.
02
Drugs
aspirin + atorvastatin + ramipril
03
Conditions
acute coronary syndrome (ACS)myocardial infarction (MI)
Beyond the preview
Go deeper on 2025-524751-32-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524751-32-00.